Pharmacological reactivity of neoplastic and non-neoplastic associated neovasculature to vasoconstrictors

International Journal of Experimental Pathology

Volumn 79, Issue 6, 1998, Pages 425-432

  Andrade, S P ^a,b   Beraldo, W T ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b Campus Pampulha ^*  (Brazil)

Author keywords

Angiogenesis; Melanoma; Pharmacological response; Tumour neovasculature

Indexed keywords

SEROTONIN; THROMBOCYTE ACTIVATING FACTOR; VASOCONSTRICTOR AGENT;

ACTIN FILAMENT; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASEMENT MEMBRANE; BLOOD VESSEL PERMEABILITY; CANCER CELL; CONTROLLED STUDY; EXTRACELLULAR MATRIX; MELANOMA; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STIMULUS RESPONSE; TUMOR VASCULARIZATION; WOUND HEALING;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MELANOMA; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 0032435594     PISSN: 09599673     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2613.1998.00081.x     Document Type: Article

References (39)

1. ABRAMOVITCH R., MEIR G. & NEEMAN M. (1995) Neovascularization induced growth of implanted C6 glioma multicellular spheroids: magnetic resonance microimaging. Cancer Res. 55, 1956-1962.
2. ANDRADE S.P., BAKHLE Y.S., HART I.R. & PIPER P.J. (1992a) Effects of tumour cells on angiogenesis and vasoconstrictor responses in sponge implants in mice. Br. J. Cancer 66, 821-826.
3. ANDRADE S.P., HART I.R. & PIPER P.J. (1992b) Inhibitors of nitric oxide synthase selectively reduce flow in tumour-associated neovasculature. Br. J. Pharmacol. 107, 1092-1095.
4. ANDRADE S.P., VIEIRA L.B.G.B., BAKHLE Y.S. & PIPER P.J. (1992c) Effects of platelet activating factor (PAF) and other vasoconstrictors on a model of angiogenesis in the mouse. Int. J. Exp. Path. 73, 503-513.
5. ANDRADE S.P., CARDOSO C.C., MACHADO R.D.P. & BERALDO W.T. (1996) Angiotensin-II-induced angiogenesis in sponge implants in mice. Int. J. Microcirc. Clin. Exp. 16, 302-307.
6. AUSPRUNK D.H. & FOLKMAN J. (1977) Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumour angiogenesis. Microvasc. Res. 14, 53-65.
7. BOONE C.W. (1965) Malignant hemangioendotheliomas produced by a subcutaneous inoculation of Balb/3T3 cell attached to glass beads. Science 188, 68-70.
8. CHAN R.C., BABBS C.F., VETTER R.J. & LAMAR C.H. (1984) Abnormal response of tumor vasculature to vasoactive drugs. J. Natl. Cancer Inst. 72, 145-150.
9. CLAFFEY K.P., BROWN L.F., DEL AGUILA L.F. ET AL. (1995) Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis. Cancer Res. 56, 172-181.
10. DENEKAMP D.E. (1991) The current status of targeting tumour vasculature as a means of cancer therapy: an overview. Int. J. Radiat. Biol. 60(1/2), 401-408.
11. DVORAK H.F. (1986) Tumors: Wounds that do not heal. N. Eng. J. Med. 315, 1650-1659.
12. FERNANDEZ L.A., TWICKER J. & MEAD A. (1985) Neovascularization produced by angiotensin II. J. Lab. Clin. Med. 105, 141-145.
13. FIDLER I.J. & KRIPKE M.L. (1977) Metastasis results from preexisting variant cells within a malignant tumour. Science 197, 893-895.
14. FOLKMAN J. & D'AMORE P. (1996) Blood vessel formation: What is the molecular basis? Cell 87, 1153-1155.
15. FOLKMAN J. & SHING Y. (1992) Angiogenesis. J. Biol. Chem. 267, 10931-10934.
16. HIRST D.G., HIRST V.K., SHAFFI K-M., PRISE V.E. & JOINER B. (1991) The influence of vasoactive agents on the perfusion of tumors growing in three different sites of the mouse. Int. J. Radiat. Biol. 60(1/2), 211-218.
17. HOFFMAN H., MCAUSLAN B., ROBERSTON D. & BURNETT E. (1976) An endothelial growth-stimulating factor from salivary glands. Exp. Cell Res. 102, 269-275.
18. HU D.E., HILEY R.C. & FAN T.P.D. (1996) Comparative studies of the angiogenic activity of vasoactive intestinal peptide, endothelins-1 and 3 and angiotensin II in a rat sponge model. Br. J. Pharmacol. 117, 545-551.
19. JACKSON A., TARANTINI F., GAMBLE S., FRIEDMAN S. & MACIAG T. (1995) The release of fibroblast growth factor-1 from NH1 3T3 cells in response to temperature involves the function of cysteine residues. J. Biol. Chem. 270, 333-336.
20. JAIN R.K. (1988) Determinants of tumor blood flow: A review. Cancer Res. 48, 2641-2646.
21. KANDEL J., BOSSEY-WETZEL E., RADVANYI F., KLAGSBRUN M., FOLKMAN J. & HANAHAN D. (1991) Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma. Cell 66, 1095-1104.
22. KIM K.J., LI B., WINER J., ARMANINI M., GILLETT N., PHILLIPS H.S. & FERRARA N. (1993) Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature 362, 841-844.
23. KLAGSBRUN M., KNIGHTON D, & FOLKMAN J. (1976) Tumor angiogensis activity in cells grown in tissue culture. Cancer Res. 36, 110-114.
24. KNIGHTON D.R., HUNT T.K., SCHEUENSTUHL H. & HALLIDAY B. (1983) Oxygen tension regulates the expression of angiogenesis factor by macrophages. Science 221, 1283-1285.
25. LAWRENCE D.A., PIRCHER R., KRYCEVE-MARTINERIE C. & JULLIEN P. (1984) Normal embryo fibroblasts release transforming growth factors in a latent form. J. Cell Physiol. 121, 184-188.
26. MCNEIL P.L., MUTHUKRISHNAN L., WARDER E. & D'AMORE P.A. (1989) Growth factors are released by mechanically wounded endothelial cells. J. Biol. Chem. 270, 333-336.
27. NAGY J.A., BROWN L.F., SENGER D.R. ET AL. (1988) Pathogenesis of tumor stroma generation: a critical role for leaky blood vessels and fibrin deposition. Biochem. Biophys. Acta 948, 305-326.
28. NEEMAN M., ABRAMOVITCH R., SCHIFFENBAUER Y.S. & TEMPEL C. (1997) Regulation of angiogenesis by hypoxic stress: from solid tumours to the ovarian follicle. Int. J. Exp. Path. 78, 57-70.
29. O'BRIEN T., CRANSTON D., FUGGLE S., BICKNELL R. & HARRIS A. (1995) Different angiogenic pathways characterize superficial and invasive bladder cancer. Cancer Res. 55, 510-513.
30. PETERSON H.I. (1991) Modification of tumour blood flow - a review. Int. J. Radiat. Biol. 60, 201-210.
31. SADOSHIMA J.I. & ISUMO S. (1993) Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts; critical role of the AT, receptor subtype. Circ. Res. 73, 413-423.
32. SHUBIK P. (1982) Vascularization of tumors: a review. J. Cancer Res. Clin. Oncol. 103, 211-226.
33. SKALLI O., ROPRAZ P., TRZECIAC A., BENZONANA G., GILLESEN D. & GABBIANI G. (1986) A monoclonal antibody against α-actin. A probe for smooth muscle differentiation. J. Cell Biol. 103, 2787-2796.
34. SPORN M.B. & ROBERTS A.B. (1986) Peptide growth factors and inflammation, tissue repair, and cancer. J. Clin. Invest. 78, 329-332.
35. STUCKER O., VICAUT E. & TEISSEIRE B. (1991) Hyper-responsiveness to 5-HT agonists by tumor-linked arterioles in mice: consequences for tumor growth. Int. J. Radiat. Biol. 60(1/2), 237-241.
36. SUZUKI M., HORI K., ABE I., SAITO S. & SATO H. (1984) Functional characterization of the microcirculation in tumors. Cancer Metast. Rev. 3, 115-175.
37. TODARO G.J. & GREEN H. (1963) Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines. J. Cell. Biol. 19, 299-313.
38. VAUPEL P., KALLINOWSKI F. & OKUNIEFF P. (1989) Blood flow, oxygen, and nutrient supply and metabolic microenvironment of human tumors: a review. Cancer Res. 49, 6449-6465.
39. WARREN B. (1979) Tumor angiogenesis. In Tumor blood circulation: angiogenesis, vascular morphology and blood flow of experimental and human tumors. Ed. HI Peterson CRC Press, Florida, pp. 49-75.